IMMUNOME INC.

Profile

Company Names

IMMUNOME INC.

Addresses

665 STOCKTON DRIVE, SUITE 300, EXTON, MA 19341

665 STOCKTON DRIVE, SUITE 300, EXTON, PA 19341

3624 MARKET STREET, SUITE 5E, PHILADELPHIA, PA 19104

3001 MARKET STREET, SUITE 140, PHILADELPHIA, PA 19104

100 EAST LANCASTER AVENUE, LIMR BUILDING, ROOM 222, WYNNEWOOD, PA 19096

100 LANCASTER AVENUE, ROOM 222, WYNNEWOOD, PA 19096

100 LANCASTER AVENUE, ROOM 227, WYNNEWOOD, PA 19096

Phone Numbers

610-321-3700
860-625-9226
215-239-6274
484-476-1396
(484) 476-1396
(610) 645-6516

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

PENNSYLVANIA

Total Amount Raised:

$70,991,097.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2021-04-28 
$27,000,054.00 
$27,000,054.00 
$0.00 
Equity 
12
2020-06-02 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
11
2019-11-04 
$9,300,000.00 
$16,800,000.00 
$7,500,000.00 
Equity 
10
2019-02-07 
$6,500,000.00 
$6,500,000.00 
$0.00 
Debt 
9
2017-05-17 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
8
2016-07-01 
$5,057,508.00 
$12,000,000.00 
$6,942,492.00 
Equity 
7
2015-11-18 
$3,634,048.00 
$8,500,000.00 
$4,865,952.00 
Equity 
6
2014-09-30 
$892,500.00 
$1,062,500.00 
$170,000.00 
Debt 
5
2014-02-19 
$735,000.00 
$800,000.00 
$65,000.00 
Debt 
4
2013-02-08 
$445,000.00 
$1,000,000.00 
$555,000.00 
Debt 
3
2012-01-04 
$145,000.00 
$1,500,000.00 
$1,355,000.00 
Debt 
2
2010-04-19 
$846,631.00 
$946,631.00 
$100,000.00 
Debt 
1
2009-09-03 
$435,356.00 
$435,356.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
BARON 
DIRECTOR
IMMUNOME INC.
SCOTT 
 
DESSAIN 
EXECUTIVE OFFICER
IMMUNOME INC.
SCOTT 
K. 
DESSAIN 
DIRECTOR, EXECUTIVE OFFICER
IMMUNOME INC.
DENNIS 
H 
GIESING 
EXECUTIVE OFFICER
IMMUNOME INC.
GREGORY 
 
HARRIMAN 
DIRECTOR
IMMUNOME INC.
GEORGE 
 
HOBBS 
DIRECTOR, EXECUTIVE OFFICER
IMMUNOME INC.
JANE 
H. 
HOLLINGSWORTH 
EXECUTIVE OFFICER, DIRECTOR
NUPATHE INC.   |  IMMUNOME INC.
DAVID 
 
KUTCHER 
EXECUTIVE OFFICER
IMMUNOME INC.   |  SAUVEGARDER INVESTMENT MANAGEMENT, INC.
JOHN 
 
LAMATTINA 
DIRECTOR
GELESIS INC   |  LIGAND PHARMACEUTICALS INC   |  IMMUNOME INC.   |  VEDANTA BIOSCIENCES, INC.
JOAN 
 
LAU 
EXECUTIVE OFFICER
AZELON PHARMACEUTICALS, INC.   |  IMMUNOME INC.
MICHAEL 
 
LEFENFELD 
DIRECTOR
SIGNA CHEMISTRY, INC.   |  IMMUNOME INC.   |  HYDROBUILDER HOLDINGS LLC
GREGORY 
P. 
LICHOLAI 
DIRECTOR
IMMUNOME INC.
MICHAEL 
J 
MORIN 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOME INC.
MICHAEL 
J. 
MORIN 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOME INC.
I 
WISTAR 
MORRIS 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  IMMUNOME INC.
I. 
WISTAR 
MORRIS 
DIRECTOR
ODYSSEY VALUE FUND OFFSHORE LTD   |  ODYSSEY VALUE FUND LP   |  IMMUNOME INC.   |  COMPLEXA INC.   |  RHOQ INC.
TIMOTHY 
J. 
PELURA 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOME INC.
MICHAEL 
D 
RAPOPORT 
DIRECTOR
IMMUNOME INC.
MICHAEL 
D. 
RAPOPORT 
DIRECTOR
IMMUNOME INC.
MICHAEL 
 
RAPP 
DIRECTOR
COMMITTED CAPITAL ACQUISITION CORP   |  IMMUNOME INC.   |  AC BLACKPOINT HOLDINGS, LLC
CORLEEN 
 
ROCHE 
EXECUTIVE OFFICER
IMMUNOME INC.
PURNANAND 
 
SARMA 
EXECUTIVE OFFICER, DIRECTOR
TARIS BIOMEDICAL INC   |  IMMUNOME INC.   |  VAXESS TECHNOLOGIES, INC.
BARBARA 
S. 
SCHILBERG 
DIRECTOR
QR PHARMA, INC.   |  IMMUNOME INC.
SANDRA 
G 
STONEMAN 
EXECUTIVE OFFICER
IMMUNOME INC.
JOEL 
 
SUSSMAN 
EXECUTIVE OFFICER
ASCENTA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  GALERA THERAPEUTICS, INC.   |  IMMUNOME INC.
JOEL 
H. 
SUSSMAN 
EXECUTIVE OFFICER
IMMUNOME INC.
PHILIP 
 
WAGENHEIM 
DIRECTOR
BHM FUNDING, LLC   |  COMMITTED CAPITAL ACQUISITION CORP   |  ZYNERBA PHARMECEUTICALS, INC.   |  HYDRO STORES INVESTMENT CORP I LLC   |  IMMUNOME INC.   |  HYDROBUILDER HOLDINGS LLC   |  SWARMER, INC
PHILIP 
R 
WAGENHEIM 
DIRECTOR
IMMUNOME INC.
PHILIP 
R. 
WAGENHEIM 
DIRECTOR, EXECUTIVE OFFICER
IMMUNOME INC.
MICHAEL 
D 
WIDLITZ 
DIRECTOR
IMMUNOME INC.
MICHAEL 
D. 
WIDLITZ 
DIRECTOR
IMMUNOME INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-05-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-04-28 
2020-06-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-02 
2019-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-04 
2019-05-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-02-07 
2017-05-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-17 
2016-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-01 
2015-12-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-18 
2015-04-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-30 
2014-10-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-30 
2014-03-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-19 
2014-03-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-19 
2013-02-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-02-08 
2012-01-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-04 
2011-06-08
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-19 
2010-10-05
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-19 
2010-10-04
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-19 
2010-05-03
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-19 
2009-09-14
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2009-09-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
BROADBAND CAPITAL MANAGEMENT LLC
48001
NONE
NONE